Target intelligence / Profile preview

Secretogranin III (SCG3)

Target
SCG3
Molecular classification
Other (Granin family protein, neuroendocrine secretory protein)
01

Overview

Secretogranin III (SCG3) is a member of the chromogranin/secretogranin family of acidic secretory proteins, primarily found in endocrine and neuroendocrine cells, including the brain and pancreas[1][2][3][4][5]. It functions as a helper protein in the regulated secretory pathway, where it helps sort and package other peptides, such as chromogranin A and adrenomedullin, into secretory granules for proper hormone processing and release[1][2][3][4]. SCG3 is involved in processing neuropeptides important for appetite regulation and may also play a role in angiogenesis through the MEK/ERK pathway[4]. Its expression is altered in diseases involving neuroendocrine or astrocytic dysfunction, and aberrant accumulation has been observed in some neurodegenerative diseases[3][4]. SCG3 is not a classical drug target (e.g., receptor, enzyme) but may serve as a disease biomarker[3][4].

Other names
Secretogranin-3SgIIISGIIIUNQ2502/PRO5990FLJ90833
02

Biological functions

Biogenesis of secretory granulesSorting of peptide hormones and intragranular proteinsEarly processing of peptide hormonesPotential angiogenesis regulation
03

Disease associations

Neurodegenerative disease (e.g., Alzheimer's disease, multiple sclerosis, major depressive disorder)Potential role in endocrine/metabolic diseasesMotility-related diarrheaParasagittal meningioma
04

Biomarkers

May be an indicator (biomarker) of astrocyte activation or neurodegenerative disease state

Beyond the preview

Go deeper on Secretogranin III (SCG3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secretogranin III (SCG3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call